CME vs FISV vs MA Stock Comparison

Cme, Fiserv and Mastercard Prices as of Nov 3, 2026 Peers: Industry group
1 more company in this comparison (VIRT) Create a free account to keep reading and compare up to 10 companies.
CME Cme Group Inc.
$304.06 +15.6% 1M +15.1% 1Y
Market cap
$109.78B
P/E
24.9x
Revenue (TTM)
$6.97B
Div. yield
–
Exchanges Financial Services
2 wins
FISV Fiserv Inc
$58.40 +31.7% 1M -10.3% 1Y
Market cap
$33.11B
P/E
11.8x
Revenue (TTM)
$20.87B
Div. yield
–
Payment Processing Technology
3 wins
MA Mastercard Inc
$647.17 +17.2% 1M +18.9% 1Y
Market cap
$592.00B
P/E
34.9x
Revenue (TTM)
$36.29B
Div. yield
–
Payment Networks Financial Services
6 wins

Head to Head

11 decided of 12

Mastercard leads on 6 of the 12 questions below (Mastercard 6, Fiserv 3, Cme 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCMEFISVMALeader
Larger companyMarket capitalisation $109.78B $33.11B $592.00B MA
Cheaper on earningsLower P/E, profitable companies only 24.9x 11.8x 34.9x FISV
Cheaper on forward earningsLower price / next fiscal year consensus EPS 25.9x 7.8x 30.8x FISV
Faster revenue growthRevenue growth, trailing twelve months +9.0% -1.2% +15.3% MA
More profitableNet margin, trailing twelve months 63.3% 13.4% 46.7% CME
Better return on capitalReturn on invested capital 11.7% 7.0% 56.6% MA
Less leveragedLower net debt / EBITDA 0.2x 3.4x 0.5x CME
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +15.1% -10.3% +18.9% MA
Better 5-year returnAnnualised price return, 5 years +6.6%/yr -10.6%/yr +14.1%/yr MA
Less volatileAnnualised volatility, 1 year 25.4% 40.1% 23.2% MA
Higher overall scoreMean of the five percentile scores vs peers 61/100 62/100 51/100 FISV

Percentile Scorecard

CMEFISVMA

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCMEFISVMA
Valuation 44 #58 of 103 89 #12 of 99 14 #831 of 965
Growth 23 #54 of 70 40 #57 of 94 64 #297 of 823
Profitability 90 #8 of 74 85 #14 of 90 99 #12 of 846
Financial Health 56 #44 of 99 29 #75 of 105 53 #424 of 899
Shareholder Returns 90 #5 of 41 69 #20 of 62 25 #547 of 732
Overall 61 62 51
  • CME ranked among 110 companies in Capital Markets
  • FISV ranked among 109 companies in Fintech
  • MA ranked among 1,003 companies in Financial Services

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCMEFISVMASPY
1 month +15.6%+31.7%+17.2% -2.0%
3 months +15.8%+4.7%+13.3% -2.2%
6 months +6.0%+2.0%+30.2% +4.2%
Year to date +11.3%-13.1%+13.4% +10.6%
1 year +15.1%-10.3%+18.9% +10.4%
3 years +45.7%-51.1%+67.6% +73.6%
3 years, per year +13.4%-21.3%+18.8% +20.2%
5 years +37.9%-42.7%+92.9% +61.6%
5 years, per year +6.6%-10.6%+14.1% +10.1%
10 years +195.2%+19.0%+523.6% +261.3%
10 years, per year +11.4%+1.8%+20.1% +13.7%

Risk

MeasureCMEFISVMASPY
Volatility, 1Y 25.4%40.1%23.2% 12.8%
Downside volatility, 1Y 27.7%42.0%22.7% 12.8%
Beta vs S&P 500, 1Y -0.400.440.23 1.00
Return / volatility, 1Y 0.59-0.260.82 0.81
Max drawdown, 5Y -33.1%-81.3%-28.6% -25.4%
From 52-week high -6.9%-16.4%-1.7% -3.2%
52-week high $326.46$69.85$658.39 $779.14
52-week low $218.58$44.36$471.55 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCMEFISVMA
P/E now vs peer median 24.7xmedian 29.4x 11.1xmedian 19.2x 33.7xmedian 13.4x
P/S now vs peer median 15.6xmedian 3.0x 1.5xmedian 2.2x 15.4xmedian 3.3x
EV/EBITDA now vs peer median 22.6xmedian 13.1x 7.3xmedian 13.4x 22.9xmedian 5.8x
P/FCF now vs peer median 25.1xmedian 14.8x 7.9xmedian 16.3x 34.8xmedian 10.7x
P/B now vs peer median 4.1xmedian 2.4x 1.2xmedian 1.9x 83.0xmedian 1.2x
PEG now vs peer median 1.80median 0.55 1.23median 0.89 1.84median 0.91

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCMEFISVMA
Revenue $6.97B $20.87B $36.29B
Gross profit – $11.73B –
Operating income $4.58B $4.66B $21.27B
Net income $4.42B $2.82B $16.96B
Free cash flow $4.33B $3.93B $16.08B
EPS (diluted) $12.31 $5.25 $19.20
Cash & equivalents $2.20B $627.00M $10.15B
Total debt $3.43B $27.89B $23.94B
Shares (diluted) 358.64M 533.70M 883.00M
Enterprise value $98.11B $29.78B $552.09B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCMEFISVMA
P/E 24.7x 11.1x 33.7x
P/FCF 25.1x 7.9x 34.8x
P/Operating cash flow 24.6x 5.3x 33.2x
P/S 15.6x 1.5x 15.4x
P/B 4.1x 1.2x 83.0x
P/Tangible book 4.5x 1.2x 534.0x
EV/EBITDA 22.6x 7.3x 22.9x
EV/EBIT 24.0x 12.5x 27.0x
EV/Revenue 15.7x 2.8x 15.8x
EV/FCF 25.3x 14.9x 35.7x
EV/Operating cash flow 24.8x 10.0x 34.0x
PEG (3Y EPS CAGR) 1.80 1.23 1.84

Growth

14 metrics
MetricCMEFISVMA
Revenue growth (1Y) 9.0% -1.2% 15.3%
Revenue CAGR (3Y) 9.2% 4.2% 14.2%
Gross profit growth (1Y) – -9.1% –
Gross profit CAGR (3Y) – 3.6% –
Operating income growth (1Y) 10.1% -26.7% 18.6%
Operating income CAGR (3Y) 12.2% 4.4% 15.4%
Net income growth (1Y) 17.3% -17.2% 19.0%
Net income CAGR (3Y) 13.1% 3.2% 15.8%
EPS growth (1Y) 19.4% -14.2% 22.0%
EPS CAGR (3Y) 13.7% 9.0% 18.3%
Operating cash flow growth (1Y) 6.4% -13.9% -3.5%
Operating cash flow CAGR (3Y) 9.3% 6.5% 15.5%
Free cash flow growth (1Y) 6.1% -23.9% -5.4%
Free cash flow CAGR (3Y) 9.4% 5.1% 15.2%

Profitability

14 metrics
MetricCMEFISVMA
Gross margin – 56.2% –
EBITDA margin 69.8% 38.2% 69.2%
Operating margin 65.7% 22.3% 58.6%
Pretax margin 82.8% 15.8% 57.6%
Net margin 63.3% 13.4% 46.7%
FCF margin 62.1% 18.8% 44.3%
Operating cash flow margin 63.5% 27.9% 46.5%
Return on equity 16.6% 10.6% 274.4%
Return on assets 2.3% 3.5% 29.3%
Return on invested capital 11.7% 7.0% 56.6%
Return on capital employed 12.3% 8.3% 63.1%
Asset turnover 0.0x 0.3x 0.6x
Cash conversion (OCF / net income) 1.0x 2.1x 1.0x
Stock comp / revenue 1.4% 1.8% 1.8%

Financial Health

11 metrics
MetricCMEFISVMA
Debt / assets 1.8% 34.5% 41.2%
Debt / equity 0.1x 1.0x 3.5x
Net debt / EBITDA 0.2x 3.4x 0.5x
Debt / FCF 0.8x 7.1x 1.5x
Liabilities / assets 86.2% 66.7% 88.4%
Equity / assets 13.8% 33.3% 11.6%
Interest coverage 26.2x 3.0x 26.2x
Current ratio 1.0x 1.0x 1.0x
Quick ratio 0.0x 0.9x 0.6x
Cash ratio 0.0x 0.0x 0.4x
Altman Z-score 0.57 1.30 10.68

Shareholder Returns

7 metrics
MetricCMEFISVMA
Dividend yield 3.3% – 0.5%
Net buyback yield – 5.2% 2.7%
Shareholder yield 3.3% 5.2% 3.3%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCMEFISVMA
Forward P/E 25.9xFY2026 7.8xFY2026 30.8xFY2026
EPS, next fiscal year $11.74FY2026 $7.44FY2026 $20.99FY2026
EPS growth, next FY +4.8%FY2026 -13.9%FY2026 +23.4%FY2026
EPS growth, the year after +19.0% +13.2% +14.7%
Revenue, next fiscal year $7.27BFY2026 $18.58BFY2026 $38.99BFY2026
Revenue growth, next FY +11.6%FY2026 -6.2%FY2026 +18.9%FY2026
Revenue growth, the year after +7.0% +3.9% +0.4%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCMEFISVMA
Held by institutions 88.9% 89.7% 87.5%
Institutions holding 1,694 1,153 3,588
Change in shares held, QoQ +0.4% +2.6% +0.6%
Institutions buying 824 500 1,590
Institutions selling 656 504 1,530
Buyers to sellers 1.26 0.99 1.04

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CMEFISVMA
CME 1.00 0.10 0.18
FISV 0.10 1.00 0.46
MA 0.18 0.46 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CME, FISV and MA?

Mastercard (MA) is the largest by market capitalisation: Cme (CME) $109.78B, Fiserv (FISV) $33.11B, Mastercard (MA) $592.00B.

Which stock is cheaper, CME, FISV and MA?

Fiserv (FISV) trades on the lowest price-to-earnings ratio (Cme (CME) 24.9x, Fiserv (FISV) 11.8x, Mastercard (MA) 34.9x). On next year's consensus earnings, Fiserv (FISV) is cheapest (Cme (CME) 25.9x, Fiserv (FISV) 7.8x, Mastercard (MA) 30.8x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Mastercard (MA) grew revenue fastest over the trailing twelve months: Cme (CME) +9.0%, Fiserv (FISV) -1.2%, Mastercard (MA) +15.3%.

Which company is more profitable?

Cme (CME) has the highest net margin (Cme (CME) 63.3%, Fiserv (FISV) 13.4%, Mastercard (MA) 46.7%). On return on invested capital, Mastercard (MA) leads (Cme (CME) 11.7%, Fiserv (FISV) 7.0%, Mastercard (MA) 56.6%).

Which stock has performed better?

Over the past year Mastercard (MA) returned the most: Cme (CME) +15.1%, Fiserv (FISV) -10.3%, Mastercard (MA) +18.9%. Over five years, Mastercard (MA) compounded fastest (Cme (CME) +6.6%/yr, Fiserv (FISV) -10.6%/yr, Mastercard (MA) +14.1%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Mastercard (MA) has been the steadiest (Cme (CME) 25.4%, Fiserv (FISV) 40.1%, Mastercard (MA) 23.2%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CME, FISV and MA?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Mastercard (MA) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.